Statistics
Publications
4
Citations
142
H-Index
4
Active since
2018
Anna Borgenvik is an author at Science for Life Laboratory specializing in neoplasia, therapeutic targeting of myc, and oncogenic myc signaling.
Publications per year
2018–2024
4
4
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Sara Bolin, Anna Borgenvik, C. Persson et al. · Oncogene · 2018 · 86 citations · Full text
Medicine, Cancer Biology, Oncology +15
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Anna Borgenvik, Karl O. Holmberg, Sara Bolin et al. · Cancer Research · 2022 · 24 citations · Full text
Medicine, Cancer Biology, Oncology +17
Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies
Karl O. Holmberg, Anna Borgenvik, Miao Zhao et al. · Cancers · 2024 · 11 citations · Full text
Medicine, Oncology, Pediatrics +17
1–4 of 4